While many studies have shown that maternal weight and nutrition in pregnancy affects offspring’s breast cancer risk, no studies have investigated the impact of paternal body weight on daughters’ risk of this disease. Here, we show that diet-induced paternal overweight around the time of conception can epigenetically reprogram father’s germ-line and modulate their daughters’ birth weight and likelihood of developing breast cancer, using a mouse model. Increased body weight was associated with changes in the miRNA expression profile in paternal sperm. Daughters of overweight fathers had higher rates of carcinogen-induced mammary tumors which were associated with delayed mammary gland development and alterations in mammary miRNA expression. The hypoxia signaling pathway, targeted by miRNAs down-regulated in daughters of overweight fathers, was activated in their mammary tissues and tumors. This study provides evidence that paternal peri-conceptional body weight may affect daughters’ mammary development and breast cancer risk and warrants further studies in other animal models and humans.
BackgroundMaternal and paternal high-fat (HF) diet intake before and/or during pregnancy increases mammary cancer risk in several preclinical models. We studied if maternal consumption of a HF diet that began at a time when the fetal primordial germ cells travel to the genital ridge and start differentiating into germ cells would result in a transgenerational inheritance of increased mammary cancer risk.MethodsPregnant C57BL/6NTac mouse dams were fed either a control AIN93G or isocaloric HF diet composed of corn oil high in n-6 polyunsaturated fatty acids between gestational days 10 and 20. Offspring in subsequent F1–F3 generations were fed only the control diet.ResultsMammary tumor incidence induced by 7,12-dimethylbenz[a]anthracene was significantly higher in F1 (p < 0.016) and F3 generation offspring of HF diet-fed dams (p < 0.040) than in the control offspring. Further, tumor latency was significantly shorter (p < 0.028) and burden higher (p < 0.027) in F1 generation HF offspring, and similar trends were seen in F3 generation HF offspring. RNA sequencing was done on normal mammary glands to identify signaling differences that may predispose to increased breast cancer risk by maternal HF intake. Analysis revealed 1587 and 4423 differentially expressed genes between HF and control offspring in F1 and F3 generations, respectively, of which 48 genes were similarly altered in both generations. Quantitative real-time polymerase chain reaction analysis validated 13 chosen up- and downregulated genes in F3 HF offspring, but only downregulated genes in F1 HF offspring. Ingenuity Pathway Analysis identified upregulation of Notch signaling as a key alteration in HF offspring. Further, knowledge-fused differential dependency network analysis identified ten node genes that in the HF offspring were uniquely connected to genes linked to increased cancer risk (ANKEF1, IGFBP6, SEMA5B), increased resistance to cancer treatments (SLC26A3), poor prognosis (ID4, JAM3, TBX2), and impaired anticancer immunity (EGR3, ZBP1).ConclusionsWe conclude that maternal HF diet intake during pregnancy induces a transgenerational increase in offspring mammary cancer risk in mice. The mechanisms of inheritance in the F3 generation may be different from the F1 generation because significantly more changes were seen in the transcriptome.Electronic supplementary materialThe online version of this article (doi:10.1186/s13058-017-0866-x) contains supplementary material, which is available to authorized users.
Maternal high fat diet has been shown to increase mammary cancer risk among female offspring. We investigated here if the increase is seen across multiple generations. For that purpose, pregnant C57BL/6NTac dams (F0) were fed either a control (CON, 6% corn oil) or an isocaloric high n-6 polyunsaturated fat (HF) diet (18% corn oil) between gestation days 8 and 21. Offspring in subsequent generations (F1-F3) were not exposed to any further dietary modifications, and kept on CON diet. Mammary tumors were initiated by priming the mammary glands with 15 mg medroxyprogesterone (MPA) at week 6, followed by a 1 mg dose of 7,12-dimethylbetz(a)anthracene (DMBA) given on weeks 7-9 for a total of 3 doses. Animals were monitored for 20 weeks after the final dose of DMBA for tumors. Both F1 and F3 generation female HF offspring exhibited a significantly higher mammary tumor incidence and tumor burden than the control offspring. In F3 generation, the increase was seen from week 12 of tumor monitoring until the end of the study. The increase in risk was preceded by a higher number of terminal end buds in the F1 and F3 generation mammary glands. Malondialdehyde (MDA) adduct levels were found to be significantly elevated in the HF group of F3 offspring, suggesting that the increased mammary cancer risk in this generation was attributed to oxidative stress. Western blot analysis of mammary glands identified significantly elevated Keap1 (a repressor of the antioxidant response) and PERK levels in HF F3 offspring; and elevated levels of Beclin-1 and p62 in both F1 and F3 generations compared with CON offspring, corroborating with the idea that oxidative stress was the culprit. miRNA analysis of F3 mammary glands showed decreased expression of mir-324-5p, mir-136 and mir-378 that target Keap1 and p62, potentially explaining the increase in Keap1 and p62 levels. Our results suggest that oxidative stress and antioxidant response plays a role in explaining transgenerational increase in mammary cancer risk among offspring exposed to high fat diet through F0 dams. Citation Format: Nguyen M. Nguyen, Fabia O. Andrade, Sonia DeAssis, Idalia Cruz, Carlos Benitez, Roger Godschalk, Leena Hilakivi-Clarke. Transgenerational inheritance of increased mammary cancer risk in the offspring of high fat diet fed dams: Changes in oxidative stress pathways. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 901.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.